EVOK – Evoke Pharma Inc
Float Short %
0.73
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
2.56
Price
11
Target Price
18
Analyst Recom
3
Performance Q
116.11
Relative Volume
Beta
-0.1
Ticker: EVOK
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-26 | EVOK | 11 | N/A | N/A | 0 |
| 2025-12-29 | EVOK | 11 | N/A | N/A | 0 |
| 2025-12-30 | EVOK | 11 | N/A | N/A | 0 |
| 2025-12-31 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-02 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-05 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-06 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-07 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-08 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-09 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-12 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-13 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-14 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-15 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-16 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-20 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-21 | EVOK | 11 | N/A | N/A | 0 |
| 2026-01-22 | EVOK | 11 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
No data found
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-26 | EVOK | -3.69 | 0 | 0.73 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.3
Avg. EPS Est. Next Quarter
Insider Transactions
-3.69
Institutional Transactions
Beta
-0.1
Average Sales Estimate Current Quarter
4
Average Sales Estimate Next Quarter
Fair Value
Quality Score
34
Growth Score
39
Sentiment Score
92
Actual DrawDown %
98.4
Max Drawdown 5-Year %
-99.7
Target Price
18
P/E
Forward P/E
PEG
P/S
1.31
P/B
5.64
P/Free Cash Flow
EPS
-2.38
Average EPS Est. Cur. Y
-1.88
EPS Next Y. (Est.)
0.68
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-36.23
Relative Volume
Return on Equity vs Sector %
-166.4
Return on Equity vs Industry %
-162.7
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.08
EBIT Estimation
Evoke Pharma, Inc.Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 3
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California. As of December 15, 2025, Evoke Pharma, Inc. operates as a subsidiary of QOL Medical, LLC.
stock quote shares EVOK – Evoke Pharma Inc Stock Price stock today
news today EVOK – Evoke Pharma Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch EVOK – Evoke Pharma Inc yahoo finance google finance
stock history EVOK – Evoke Pharma Inc invest stock market
stock prices EVOK premarket after hours
ticker EVOK fair value insiders trading